Adverum Biotechnologies Inc (ADVM)
10.43
+0.43
(+4.30%)
USD |
NASDAQ |
May 03, 16:00
10.47
+0.04
(+0.38%)
After-Hours: 20:00
Adverum Biotechnologies Market Cap: 216.47M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 216.47M |
| May 02, 2024 | 207.55M |
| May 01, 2024 | 203.19M |
| April 30, 2024 | 201.74M |
| April 29, 2024 | 197.79M |
| April 26, 2024 | 190.74M |
| April 25, 2024 | 194.89M |
| April 24, 2024 | 211.49M |
| April 23, 2024 | 228.30M |
| April 22, 2024 | 235.36M |
| April 19, 2024 | 235.36M |
| April 18, 2024 | 231.42M |
| April 17, 2024 | 235.57M |
| April 16, 2024 | 240.96M |
| April 15, 2024 | 239.30M |
| April 12, 2024 | 243.46M |
| April 11, 2024 | 248.44M |
| April 10, 2024 | 248.64M |
| April 09, 2024 | 249.27M |
| April 08, 2024 | 261.10M |
| April 05, 2024 | 261.93M |
| April 04, 2024 | 273.34M |
| April 03, 2024 | 277.08M |
| April 02, 2024 | 278.12M |
| April 01, 2024 | 288.29M |
| Date | Value |
|---|---|
| March 28, 2024 | 293.47M |
| March 27, 2024 | 304.27M |
| March 26, 2024 | 293.68M |
| March 25, 2024 | 310.29M |
| March 22, 2024 | 333.32M |
| March 21, 2024 | 306.13M |
| March 20, 2024 | 315.47M |
| March 19, 2024 | 342.46M |
| March 18, 2024 | 367.36M |
| March 15, 2024 | 352.83M |
| March 14, 2024 | 359.06M |
| March 13, 2024 | 373.59M |
| March 12, 2024 | 375.66M |
| March 11, 2024 | 371.51M |
| March 08, 2024 | 390.19M |
| March 07, 2024 | 398.18M |
| March 06, 2024 | 383.66M |
| March 05, 2024 | 389.88M |
| March 04, 2024 | 408.55M |
| March 01, 2024 | 408.55M |
| February 29, 2024 | 410.62M |
| February 28, 2024 | 408.11M |
| February 27, 2024 | 414.33M |
| February 26, 2024 | 403.97M |
| February 23, 2024 | 414.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
53.85M
Minimum
Dec 27 2022
2.059B
Maximum
Jun 23 2020
494.53M
Average
232.54M
Median
Jul 28 2021
Market Cap Benchmarks
| Karyopharm Therapeutics Inc | 130.03M |
| Ardelyx Inc | 2.029B |
| Minerva Neurosciences Inc | 16.57M |
| Arcutis Biotherapeutics Inc | 919.77M |
| 4D Molecular Therapeutics Inc | 1.313B |
Market Cap Related Metrics
| Price to Book Value | 2.594 |
| Price | 10.43 |
| Earnings Yield | -111.2% |